A Buzyn
Overview
Explore the profile of A Buzyn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bige N, Arnulf B, Hummel A, De Keyser E, Royal V, Buzyn A, et al.
NDT Plus
. 2015 May;
2(2):143-6.
PMID: 25949312
Extramedullary plasmacytomas (EMP) rarely occur during the course of multiple myeloma (MM). Most frequent reported sites are superior respiratory airways, pleura, lung, lymph nodes, skin, subcutaneous and soft tissues, testicles...
2.
Lengline E, Chevret S, Moreau A, Pene F, Blot F, Bourhis J, et al.
Bone Marrow Transplant
. 2015 Mar;
50(6):840-5.
PMID: 25798675
Intensive care unit (ICU) admission is associated with high mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Whether mortality has decreased recently is unknown. The 497 adult allogeneic HSCT...
3.
Basak G, de Wreede L, van Biezen A, Wiktor-Jedrzejczak W, Halaburda K, Schmid C, et al.
Bone Marrow Transplant
. 2012 Nov;
48(6):837-42.
PMID: 23178548
Peripheral blood used as a source of stem cells for transplantation (PBSCT) is known to exert stronger immune-mediated effects compared with BM (BMT). We decided to retrospectively analyze the impact...
4.
Chantepie S, Mohty M, Tabrizi R, Robin M, Deconinck E, Buzyn A, et al.
Bone Marrow Transplant
. 2012 Nov;
48(5):684-90.
PMID: 23165497
To assess the role of hematopoietic SCT (HSCT) in adult ALL patients with central nervous system involvement at diagnosis, we retrospectively analyzed 90 patients who underwent autologous HSCT (auto-HSCT group;...
5.
Le Gouill S, Kroger N, Dhedin N, Nagler A, Bouabdallah K, Yakoub-Agha I, et al.
Ann Oncol
. 2012 Mar;
23(10):2695-2703.
PMID: 22440229
Background: Despite therapeutic approach that combines rituximab-containing chemotherapy, followed or not by autologous stem cell transplantation (auto-SCT), mantle cell lymphoma (MCL) patients experience relapses. Reduced-intensity conditioning allogeneic stem cell transplantation...
6.
Marie I, Guillevin L, Menard J, Hatron P, Cherin P, Amoura Z, et al.
Autoimmun Rev
. 2011 Nov;
11(9):615-20.
PMID: 22079677
The aims of this present study were to: 1) assess the characteristics of hematological malignancies in polymyositis/polymyositis (PM/DM) patients; and 2) determine predictive variables of hematological malignancies in PM/DM patients....
7.
Bay J, Cabrespine A, Faucher C, Tabrizi R, Bordigoni P, Berceanu A, et al.
Biol Blood Marrow Transplant
. 2011 Jul;
18(2):250-6.
PMID: 21745455
The purpose of this paper is to describe the outcome of patients who underwent double allogeneic hematopoietic stem cell transplantation (AHSCT) with reduced-intensity conditioning regimens (RIC). Forty-five patients who received...
8.
Jantunen E, Canals C, Attal M, Thomson K, Milpied N, Buzyn A, et al.
Ann Oncol
. 2011 Apr;
23(1):166-171.
PMID: 21467125
Background: Limited experience is available on the feasibility and efficacy of autologous stem-cell transplantation (ASCT) in patients with mantle cell lymphoma (MCL) beyond 65 years. Design And Methods: We analysed...
9.
Vignon M, Michonneau D, Baixench M, Al-Nawakil C, Bouscary D, Buzyn A, et al.
Bone Marrow Transplant
. 2010 Nov;
46(9):1276-7.
PMID: 21113187
No abstract available.
10.
Mohty M, Labopin M, Balere M, Socie G, Milpied N, Tabrizi R, et al.
Leukemia
. 2010 Oct;
24(11):1867-74.
PMID: 20882046
This retrospective report assessed the impact of rabbit antithymocyte globulins (ATG), incorporated within a standard myeloablative conditioning regimen prior to allogeneic stem cell transplantation (allo-SCT) using human leukocyte antigen-matched unrelated...